Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

'Report Forecasts That Spending on eMarketing/promotion by the Pharmaceutical Industry Will Grow Steadily from 2006, Reaching Over $480m by 2011' says visiongain report.


SAN FRANCISCO San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden  & LONDON -- The purpose of this visiongain report is to analyse an·a·lyse  
v. Chiefly British
Variant of analyze.


analyse or US -lyze
Verb

[-lysing, -lysed] or -lyzing,
 the extent to which online e-solutions will contribute to the pharmaceutical sector during the period 2006-2011. Report author Dr Gordon Low said, "Pharmaceutical eMarketing to consumers and prescribing doctors will continue to grow steadily. Online technologies will become increasingly important as mass-media DTC DTC

See: Depository Transfer Check


DTC

See: Depository Trust Company


DTC

See Depository Trust Company (DTC).
 advertising faces growing resistance from consumers and regulators. Also, diminishing returns diminishing returns

the characteristic of any production system in which increases in variable inputs result in increasing reduction of total output. An indicator of when to stop making additional inputs to the system, when the input exceeds the additional output.
 from medical sales forces will drive the industry further towards eDetailing." Nevertheless, spending on other promotional channels -especially traditional detailing - will overshadow o·ver·shad·ow  
tr.v. o·ver·shad·owed, o·ver·shad·ow·ing, o·ver·shad·ows
1. To cast a shadow over; darken or obscure.

2. To make insignificant by comparison; dominate.
 investments in pharmaceutical eMarketing from 2006-2011, visiongain predicts.

In this report, visiongain forecasts that spending on eMarketing/promotion by the pharmaceutical industry will grow steadily from 2006-2011, reaching over $480m by 2011. There will also be an expansion of ePrescribing and online sales of pharmaceuticals. The Internet Internet

Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the
 is an ideal channel for transmitting transmitting,
v to send and receive information, signals, and so on; allows a therapist to perceive a client's physical, emotional, and spiritual states.
 both brand-specific and educational campaigns, especially through interactive content. The potential for improved efficiency and cost savings are great, both to industry and other healthcare providers. There are also great opportunities for suppliers of technology platforms for online healthcare.

ePharma: The Online Pharmaceutical Industry, 2006-2011 examines eMarketing, ePrescribing and online drug sales critically through comprehensive primary and secondary research. In addition to consultation with experts in eMarketing and ePrescribing, this research involved a detailed study of policy documents, industrial reports and relevant news. Importantly, Visiongain applied techniques such as financial forecasting, SWOT analyses and qualitative projections. The result is a comprehensive market-based report with detailed analysis and informed opinion.

It is therefore vital for pharmaceutical companies to invest in online marketing and sales technologies now, to harness their great potential and to achieve pre-emptive pre·emp·tive or pre-emp·tive  
adj.
1. Of, relating to, or characteristic of preemption.

2. Having or granted by the right of preemption.

3.
a.
 competitive advantages. The range of electronic solutions for pharmaceutical sales, marketing and prescribing is vast, with both the Internet and mobile communications showing significant promise.

Notes for editors:

To receive your complimentary overview of this report please send an email to Sara Peerun sara.peerun@visiongain.com, telephone Sara on +44 (0) 20 8767 6711 or visit the media section on www.visiongainintelligence.com. Please include your full name, title of publication, contact telephone number, email and details of where you saw this release. Upon receipt of this information, an overview will be emailed to you.

Background:

Visiongain is one of the fastest growing and most innovative independent media companies in Europe today Europe Today is a daily radio news show on the BBC World Service about public affairs throughout Europe. It is presented by Audrey Carville at 17:00 GMT every weekday. External links
  • Europe Today official website
. Based in London, UK, visiongain produce a host of business-2-business conferences, newsletters, management reports and E-Zines focusing on the Financial markets, the Pharmaceutical, Telecoms industries and the Defence sector.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 28, 2006
Words:417
Previous Article:New York Stock Exchange Virtual Forum Webcast Alert: Infineon Technologies AG Presentation at Semiconductors Virtual Forum on Monday, July 31, 2006,...
Next Article:Vornado to Redeem $45 Million of 8.25% Series D-9 Cumulative Redeemable Preferred Units.
Topics:



Related Articles
'Pfizer at a Pivotal Moment in Its History and the Entire Pharmaceutical Industry Needs to Pay Attention' Says Visiongain.
'Generic Drugs Are Experiencing Faster Sales Growth Than Many Branded Ones, and This Trend is Set to Continue', Says visiongain.
Yano Research Institute Releases Report on Japanese Pharmaceutical Market.
The GI Market Recently Entered a Crucial Phase, with Mounting Commercial Pressures Affecting Revenue Generation and Causing Market Participants to...
Visiongain Report Predicts Dramatic Change for the Japanese Pharma Market.
The Generic Industry Will Benefit From Lack of Innovative Drugs says visiongain Report.
Omnitrope Breaks Biogeneric Barriers Says visiongain Report.
The Report 'The Outlook for Pharmaceuticals: China' Shows Us Healthcare Provision is Extremely Uneven in China.
Biotech to See 10.1% Sales CAGR Between 2005 and 2011 According to New Report.
The Ukraine Pharmaceuticals & Healthcare Report Provides Independent Forecasts and Competitive Intelligence on Ukraine's Pharmaceuticals & Healthcare...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles